Your session is about to expire
← Back to Search
Behavioral Intervention
Packaging Imagery for Cannabis Use
N/A
Waitlist Available
Led By Beth Reboussin, PhD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after exposure to product packaging - up to 1 min
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to understand how people's opinions about cannabis edibles are influenced by the packaging images on the products.
Who is the study for?
This trial is for US residents aged 18-65 who have not participated in a related previous experiment. It includes both past year cannabis users and non-users, with specific participation quotas for individuals identifying as Hispanic (up to 16%) or Black/African American (up to 13%).
What is being tested?
The study aims to evaluate how packaging imagery on cannabis edibles affects people's perception of the product's appeal, potential harm, and their willingness to try it. Participants will be exposed to products with or without such imagery.
What are the potential side effects?
Since this trial involves perceptions rather than ingestion of substances, traditional physical side effects are not applicable. However, exposure to the packaging could influence attitudes towards cannabis use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after exposure to product packaging - up to 1 min
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after exposure to product packaging - up to 1 min
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Harm Perceptions (Absolute) Scoring
Product Appeal Scoring
Willingness to Try Product Scoring
Secondary study objectives
Appeal to Children Scoring
Harm Perceptions (Relative) Scoring
Perception of Quality Scoring
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
5Treatment groups
Experimental Treatment
Group I: No Imagery (Control)Experimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) without any added packaging imagery.
Group II: Nature ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a nature theme.
Group III: Medical ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a medical theme.
Group IV: Flavor ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in a flavor theme.
Group V: Animal ImageryExperimental Treatment1 Intervention
Four edible product packages (gummies, chocolate, mints, cookies) with package imagery in an animal theme.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Packaging imagery
2024
N/A
~1260
No Imagery (Control)
2024
N/A
~1260
Find a Location
Who is running the clinical trial?
Wake Forest University Health SciencesLead Sponsor
1,361 Previous Clinical Trials
1,038,749 Total Patients Enrolled
1 Trials studying Cannabis Use
2,731 Patients Enrolled for Cannabis Use
National Institute on Drug Abuse (NIDA)NIH
2,568 Previous Clinical Trials
3,284,394 Total Patients Enrolled
33 Trials studying Cannabis Use
6,136 Patients Enrolled for Cannabis Use
Beth Reboussin, PhDPrincipal InvestigatorWake Forest University Health Sciences
1 Previous Clinical Trials
2,731 Total Patients Enrolled
1 Trials studying Cannabis Use
2,731 Patients Enrolled for Cannabis Use
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger